Dendrimers for biomedical applications

Group leader

Francisco Javier de la Mata de la Mata

javier.delamata(ELIMINAR)@uah.es

Tlf.: +34 91 8854654

Principal Investigator

  • Rafael Gómez Ramírez

Collaborators

  • Javier Sánchez-Nieves Fernández
  • Maria Sánchez Milla
  • Jesús Cano Sierra
  • Paula Ortega López
  • Gabriel Mencía Berlinches
  • Andrea Barrios Gumiel
  • Jael Fernández Cadenas
  • Natalia Sanz del Olmo
  • Tamara Rodríguez Prieto
  • Matilde Alique Aguilar
  • Rafael Ramírez Chamond
  • Sandra García Gallego
  • Sara Quintana Sánchez
  • Cornelia Emeritina Peña González
  • Tania Lozano de la Cruz
  • Ángela Martín-Serrano Ortiz
Imagen equipo

Group leader

Francisco Javier de la Mata de la Mata

javier.delamata(ELIMINAR)@uah.es

Tlf.: +34 91 8854654

Principal Investigator

  • Rafael Gómez Ramírez

Collaborators

  • Javier Sánchez-Nieves Fernández
  • Maria Sánchez Milla
  • Jesús Cano Sierra
  • Paula Ortega López
  • Gabriel Mencía Berlinches
  • Andrea Barrios Gumiel
  • Jael Fernández Cadenas
  • Natalia Sanz del Olmo
  • Tamara Rodríguez Prieto
  • Matilde Alique Aguilar
  • Rafael Ramírez Chamond
  • Sandra García Gallego
  • Sara Quintana Sánchez
  • Cornelia Emeritina Peña González
  • Tania Lozano de la Cruz
  • Ángela Martín-Serrano Ortiz

Strategic objectives

  • Synthesize a platform of dendritic systems with the capacity to act as non-viral vectors and in the transport of drugs and nucleic acids.
  • Synthesize a platform of dendritic systems with a therapeutic activity against cancer, microbial diseases or as antiviral agents.
  • Establish collaborations with groups within the Institute with common research interests.
  • Participate in European project applications, for which the Institute is eligible to partipate.

Research lines

  • Synthesis of carbosilane dendritic systems for application as non-viral vectors of drugs or nucleic acids, or as therapeutic agents.
  • Dendronization of molecules of pharmacological interest (drugs, peptides, antibodies, etc.)
  • Preparation of carbosilane metal dendritic systems aimed at bio-inorganic applications.
  • Dendronization of nanostructured materials for application in biomedicine.
  • Application of dendritic systems against microbial resistance.
  • Application of dendritic systems against viruses, particularly HIV.
  • Applications of dendritic systems against cancer.
  • Applications of dendritic systems against neurodegenerative diseases.

Location

Dpt. Organic and Inorganic Chemistry


Pharmacy Faculty
Alcala University
+34 91 885 4654

Link to UAH group

Keywords

Dendrimer, dendron, nanoparticle, carbosilane, biomedicine, cancer, HIV, microbial resistance.